Balance Sheet Data
Gilead Sciences, Inc. (GILD)
$78.05
-1.31 (-1.65%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Total Cash | 31,512 | 25,840 | 7,910 | 7,829 | 7,630 | 19,925.44 | 21,018.41 | 22,171.34 | 23,387.51 | 24,670.40 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 3,327 | 3,582 | 4,892 | 4,493 | 4,777 | 4,879.03 | 5,146.66 | 5,428.98 | 5,726.77 | 6,040.91 |
Account Receivables (%) | ||||||||||
Inventories | 814 | 2,067 | 3,014 | 2,734 | 2,820 | 2,615.52 | 2,758.99 | 2,910.33 | 3,069.97 | 3,238.36 |
Inventories (%) | ||||||||||
Accounts Payable | 790 | 713 | 844 | 705 | 905 | 924.57 | 975.29 | 1,028.79 | 1,085.22 | 1,144.75 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -924 | -825 | -650 | -579 | -728 | -879.02 | -927.23 | -978.09 | -1,031.75 | -1,088.34 |
Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.